BCTXZ Earnings BriaCell Therapeutics Corp.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q3 2026 | 2026-04-30 | -5.73 | 2026-06-09 | 10-Q |
| Q2 2026 | 2026-01-31 | -6.58 | 2026-03-10 | 10-Q |
| Q1 2026 | 2025-10-31 | -4.35 | 2025-12-11 | 10-Q |
| FY 2025 | 2025-07-31 | -62.19 | 2025-10-16 | 10-K |
| Q3 2026 | 2025-04-30 | -67.08 | 2026-06-09 | 10-Q |
| Q2 2026 | 2025-01-31 | -54.35 | 2026-03-10 | 10-Q |
| Q1 2026 | 2024-10-31 | -32.67 | 2025-12-11 | 10-Q |
| FY 2025 | 2024-07-31 | -43.68 | 2025-10-16 | 10-K |
| Q3 2025 | 2024-04-30 | -3.36 | 2025-06-16 | 10-Q |
| Q2 2025 | 2024-01-31 | -5.04 | 2025-03-12 | 10-Q |
| Q1 2025 | 2023-10-31 | -0.50 | 2024-12-16 | 10-Q |
| FY 2024 | 2023-07-31 | -1.30 | 2024-10-29 | 10-K |
| Q3 2024 | 2023-04-30 | -1.15 | 2024-06-14 | 10-Q |
| Q2 2024 | 2023-01-31 | -0.84 | 2024-03-18 | 10-Q |
| Q1 2024 | 2022-10-31 | -0.07 | 2023-12-14 | 10-Q |
| FY 2023 | 2022-07-31 | -1.73 | 2023-10-25 | 10-K |
| Q3 2023 | 2022-04-30 | -1.70 | 2023-06-14 | 10-Q |
| Q2 2023 | 2022-01-31 | -1.05 | 2023-03-16 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.